Abstract
Pretreatment with β-naphthoflavone (BNF) inhibits aflatoxin B1 (AFB1) hepatocarcinogenesis in the rat by stimulation of aflatoxin M1 (AFM1) hydroxylation. We have now examined the effect of BNF pretreatment of rats on AFB1-hydroxylations, AFB1- DNA binding and AFB1-glutathione (AFB1-SG) conjugation in liver in vitro, in vivo and in isolated hepatocytes. Male Fischer rats were injected i.p. with either corn oil or BNF (25 mg/kg body weight) 24 h before for in vitro and in isolated hepatocyte studies. Cytochrome P-450 contents in BNF-treated rat liver microsomes and hepatocytes were 170% and 200% of controls, respectively. At two AFB1- concentrations (2 µM and 100 µM), AFB1- epoxidation measured as AFB1-DNA binding and AFM1 hydroxylation were 60% and 300% of controls, respectively. At low AFBl level (33 nM), AFB1-binding and AFM1 formation in BNF-treated hepatocytes were 40% and 225% of controls, respectively. Formation of AFB1-SG, aflatoxin Q1 and aflatoxin P1 were not affected significantly. Hepatic nuclear AFB1-DNA binding 2 h after i.p. injection of 0.4 mg [3H]AFB1/kg body wt. in BNF-treated rats was 60% of controls. The overall data indicate that lower AFB1-DNA binding in addition to higher inactivation via AFM1 hydroxylation are responsible for the inhibition of AFB1 hepato- carcinogenesis by BNF pretreatment of rats. It is suggested that this inhibition of AFB1-DNA binding may be a direct result of lower levels of constitutive cytochromes P-450 responsible for AFB1-epoxidation.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Santhanam, K., Ho, L., Gopalan-Kriczky, P. et al. A mechanism of inhibition of aflatoxin B(1) hepatocarcinogenesis by β-naphthoflavone pretreatment of rats. Exp Mol Med 28, 135–140 (1996). https://doi.org/10.1038/emm.1996.21
Published:
Issue Date:
DOI: https://doi.org/10.1038/emm.1996.21